The authors reply

New England Journal of Medicine

Volumn 369, Issue 3, 2013, Pages 283-284

  Wilson, Wyndham H ^a   Grant, Cliona ^a   Dunleavy, Kieron ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; RITUXIMAB; VINCRISTINE; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CARDIOTOXICITY; COMPARATIVE EFFECTIVENESS; DRUG COST; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; HUMAN; LETTER; OUTCOME ASSESSMENT; PRIMARY MEDIASTINAL B CELL LYMPHOMA; PRIORITY JOURNAL; RISK FACTOR; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT; FEMALE; LARGE CELL LYMPHOMA; MALE; NOTE;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE;

EID: 84880421714     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1305983     Document Type: Letter

References (5)

1. Rieger M, Osterborg A, Pettengell R, et al. Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study. Ann Oncol 2011;22:664-70.
2. Lipshultz SE, Colan SD, Gelber RD, Perez-Atayde AR, Sallan SE, Sanders SP. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 1991;324:808-15.
3. Castellino SM, Geiger AM, Mertens AC, et al. Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood 2011;117:1806-16.
4. Kenney LB, Laufer MR, Grant FD, Grier H, Diller L. High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer 2001;91:613-21. (Pubitemid 32105709)
5. Longo DL. Radiation therapy in the treatment of Hodgkin's disease - do you see what I see? J Natl Cancer Inst 2003;95:928-9. (Pubitemid 36896700)